Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease. [electronic resource]
Producer: 19940128Description: 113-7 p. digitalISSN:- 0029-7844
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cyclophosphamide -- administration & dosage
- Dactinomycin -- administration & dosage
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Methotrexate -- administration & dosage
- Pregnancy
- Prognosis
- Remission Induction
- Risk Factors
- Trophoblastic Neoplasms -- drug therapy
- Uterine Neoplasms -- drug therapy
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.